MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
Nitecki R, Ramirez PT, Dundr P, Nemejcova K, Ribeiro R, Vieira Gomes MT, Schmidt RL, Bedoya L, Isla DO, Pareja R, Rendón Pereira GJ, Lopez A, Kushner D, Cibula D.
Nitecki R, et al. Among authors: schmidt rl.
Int J Gynecol Cancer. 2023 Nov 6;33(11):1684-1689. doi: 10.1136/ijgc-2023-004711.
Int J Gynecol Cancer. 2023.
PMID: 37652529
Clinical Trial.